High-salt transcription from enzymatically gapped promoters nets higher yields and purity of transcribed RNAs

Author:

MalagodaPathiranage Kithmie1,Cavac Elvan1,Chen Tien-Hao2,Roy Bijoyita2ORCID,Martin Craig T1ORCID

Affiliation:

1. Department of Chemistry, University of Massachusetts Amherst , Amherst, MA 01003, USA

2. RNA and Genome Editing, New England Biolabs , Beverly, MA 01938, USA

Abstract

AbstractT7 RNA polymerase is commonly used to synthesize large quantities of RNA for a wide variety of applications, from basic science to mRNA therapeutics. This in vitro system, while showing high fidelity in many ways, is also well known for producing longer than encoded RNA products, particularly under high-yield reaction conditions. Specifically, the resulting product pool is contaminated by an often disperse collection of longer cis-primed extension products. In addition to reducing yield via the conversion of correctly encoded RNA to longer products, self-primed extension generates partially double-stranded RNAs that can trigger the innate immune response. Extensive and low-yield purifications are then required to produce therapeutic RNA. Under high-yield conditions, accumulating concentrations of RNA effectively compete with promoter DNA for polymerase binding, driving self-primed extension at the expense of correct initiation. In the current work, we introduce a simple and novel modification in the DNA to strengthen promoter binding, shifting the balance back toward promoter-driven synthesis and so dramatically reducing self-primed extension. The result is higher yield of the encoded RNA at the outset and reduced need for extensive purifications. The approach can readily be applied to the synthesis of mRNA-length products under high-yield conditions.

Funder

National Institutes of Health

National Science Foundation

New England Biolabs

Publisher

Oxford University Press (OUP)

Subject

Genetics

Reference33 articles.

1. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N. Engl. J. Med.,2021

2. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine;Polack;N. Engl. J. Med.,2020

3. mRNA vaccines—a new era in vaccinology;Pardi;Nat. Rev. Drug Discov.,2018

4. CRISPR-based diagnostics;Kaminski;Nat. Biomed. Eng.,2021

5. CRISPR diagnosis and therapeutics with single base pair precision;Lee;Trends Mol. Med.,2020

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3